255 related articles for article (PubMed ID: 22067658)
1. Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders.
Glinskii AB; Ma S; Ma J; Grant D; Lim CU; Guest I; Sell S; Buttyan R; Glinsky GV
Cell Cycle; 2011 Oct; 10(20):3571-97. PubMed ID: 22067658
[TBL] [Abstract][Full Text] [Related]
2. Identification of intergenic trans-regulatory RNAs containing a disease-linked SNP sequence and targeting cell cycle progression/differentiation pathways in multiple common human disorders.
Glinskii AB; Ma J; Ma S; Grant D; Lim CU; Sell S; Glinsky GV
Cell Cycle; 2009 Dec; 8(23):3925-42. PubMed ID: 19923886
[TBL] [Abstract][Full Text] [Related]
3. The riddle of intergenic disease-associated loci.
Manolio TA; Chanock SJ
Cell Cycle; 2012 Jan; 11(1):15-6. PubMed ID: 22193034
[No Abstract] [Full Text] [Related]
4. Bridging the gaps: from risk loci via non-coding RNAs to gene networks and prostate cancer phenotypes.
Mills IG
Cell Cycle; 2011 Dec; 10(24):4204. PubMed ID: 22127204
[No Abstract] [Full Text] [Related]
5. Disease phenocode analysis identifies SNP-guided microRNA maps (MirMaps) associated with human "master" disease genes.
Glinsky GV
Cell Cycle; 2008 Dec; 7(23):3680-94. PubMed ID: 19029827
[TBL] [Abstract][Full Text] [Related]
6. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
Zheng SL; Sun J; Cheng Y; Li G; Hsu FC; Zhu Y; Chang BL; Liu W; Kim JW; Turner AR; Gielzak M; Yan G; Isaacs SD; Wiley KE; Sauvageot J; Chen HS; Gurganus R; Mangold LA; Trock BJ; Gronberg H; Duggan D; Carpten JD; Partin AW; Walsh PC; Xu J; Isaacs WB
J Natl Cancer Inst; 2007 Oct; 99(20):1525-33. PubMed ID: 17925536
[TBL] [Abstract][Full Text] [Related]
7. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
[TBL] [Abstract][Full Text] [Related]
8. Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry.
Pal P; Xi H; Guha S; Sun G; Helfand BT; Meeks JJ; Suarez BK; Catalona WJ; Deka R
Prostate; 2009 Oct; 69(14):1548-56. PubMed ID: 19562729
[TBL] [Abstract][Full Text] [Related]
9. Association between genetic variations at 8q24 and prostate cancer risk in Mexican Men.
Silva-Ramirez B; Macías-González EJ; Frausto-Valdes OS; Calao-Pérez MB; Ibarra-Pérez DI; Torres-García JE; Aragón-Tovar AR; Peñuelas-Urquides K; González-Escalante LA; Bermúdez de León M
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):507-512. PubMed ID: 34599275
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome.
Du M; Yuan T; Schilter KF; Dittmar RL; Mackinnon A; Huang X; Tschannen M; Worthey E; Jacob H; Xia S; Gao J; Tillmans L; Lu Y; Liu P; Thibodeau SN; Wang L
Hum Mol Genet; 2015 Jan; 24(1):154-66. PubMed ID: 25149474
[TBL] [Abstract][Full Text] [Related]
11. Common 8q24 sequence variations are associated with Asian Indian advanced prostate cancer risk.
Tan YC; Zeigler-Johnson C; Mittal RD; Mandhani A; Mital B; Rebbeck TR; Rennert H
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2431-5. PubMed ID: 18768513
[TBL] [Abstract][Full Text] [Related]
12. Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5.
Kim T; Cui R; Jeon YJ; Lee JH; Lee JH; Sim H; Park JK; Fadda P; Tili E; Nakanishi H; Huh MI; Kim SH; Cho JH; Sung BH; Peng Y; Lee TJ; Luo Z; Sun HL; Wei H; Alder H; Oh JS; Shim KS; Ko SB; Croce CM
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4173-8. PubMed ID: 24594601
[TBL] [Abstract][Full Text] [Related]
13. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.
Wasserman NF; Aneas I; Nobrega MA
Genome Res; 2010 Sep; 20(9):1191-7. PubMed ID: 20627891
[TBL] [Abstract][Full Text] [Related]
14. Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer.
Zuber V; Bettella F; Witoelar A; ; ; ; ; Andreassen OA; Mills IG; Urbanucci A
BMC Genomics; 2017 Mar; 18(1):270. PubMed ID: 28359301
[TBL] [Abstract][Full Text] [Related]
15. In-silico identification and functional validation of allele-dependent AR enhancers.
Garritano S; Romanel A; Ciribilli Y; Bisio A; Gavoci A; Inga A; Demichelis F
Oncotarget; 2015 Mar; 6(7):4816-28. PubMed ID: 25693204
[TBL] [Abstract][Full Text] [Related]
16. SNP-guided microRNA maps (MirMaps) of 16 common human disorders identify a clinically accessible therapy reversing transcriptional aberrations of nuclear import and inflammasome pathways.
Glinsky GV
Cell Cycle; 2008 Nov; 7(22):3564-76. PubMed ID: 19001869
[TBL] [Abstract][Full Text] [Related]
17. RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.
Porkka KP; Tammela TL; Vessella RL; Visakorpi T
Genes Chromosomes Cancer; 2004 Jan; 39(1):1-10. PubMed ID: 14603436
[TBL] [Abstract][Full Text] [Related]
18. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility.
Chung S; Nakagawa H; Uemura M; Piao L; Ashikawa K; Hosono N; Takata R; Akamatsu S; Kawaguchi T; Morizono T; Tsunoda T; Daigo Y; Matsuda K; Kamatani N; Nakamura Y; Kubo M
Cancer Sci; 2011 Jan; 102(1):245-52. PubMed ID: 20874843
[TBL] [Abstract][Full Text] [Related]
19. Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population.
Terada N; Tsuchiya N; Ma Z; Shimizu Y; Kobayashi T; Nakamura E; Kamoto T; Habuchi T; Ogawa O
Prostate; 2008 Nov; 68(15):1689-95. PubMed ID: 18726982
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.
Yeager M; Orr N; Hayes RB; Jacobs KB; Kraft P; Wacholder S; Minichiello MJ; Fearnhead P; Yu K; Chatterjee N; Wang Z; Welch R; Staats BJ; Calle EE; Feigelson HS; Thun MJ; Rodriguez C; Albanes D; Virtamo J; Weinstein S; Schumacher FR; Giovannucci E; Willett WC; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Gelmann EP; Tucker M; Gerhard DS; Fraumeni JF; Hoover R; Hunter DJ; Chanock SJ; Thomas G
Nat Genet; 2007 May; 39(5):645-9. PubMed ID: 17401363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
